Methylation-regulated miR-149 modulates chemoresistance by targeting GlcNAc N-deacetylase/N-sulfotransferase-1 in human breast cancer

FEBS Journal

Volumn 281, Issue 20, 2014, Pages 4718-4730

  He, Dong Xu ^a   Gu, Xiao Ting ^a   Li, You Ran ^a   Jiang, Li ^a   Jin, Jian ^a   Ma, Xin ^a  

^a JIANGNAN UNIVERSITY   (China)

Author keywords

Chemoresistance; GlcNAc N deacetylase N sulfotransferase 1; Heparan sulfate; Methylation; MiR 149

Indexed keywords

ANTHRACYCLINE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLYPICAN 1; HEPARAN SULFATE; HEPARANASE; MICRORNA; PROTEIN MIR 149; PROTEIN NDST1; TAXANE DERIVATIVE; TUMOR PROTEIN; UNCLASSIFIED DRUG; 5' UNTRANSLATED REGION; ANTINEOPLASTIC ANTIBIOTIC; HEPARITIN SULFOTRANSFERASE; MESSENGER RNA; MIRN149 MICRORNA, HUMAN; SULFOTRANSFERASE;

5' UNTRANSLATED REGION; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER INHIBITION; DOWN REGULATION; DRUG RESISTANCE; DRUG TARGETING; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; RECURRENCE FREE SURVIVAL; RNA METHYLATION; SIGNAL TRANSDUCTION; WILD TYPE; BREAST NEOPLASMS; DNA METHYLATION; DRUG EFFECTS; ENZYME IMMUNOASSAY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

5' UNTRANSLATED REGIONS; ANTIBIOTICS, ANTINEOPLASTIC; BLOTTING, WESTERN; BREAST NEOPLASMS; DNA METHYLATION; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPARITIN SULFATE; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION, FLUORESCENCE; MICRORNAS; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SULFOTRANSFERASES; TUMOR CELLS, CULTURED;

EID: 84915759818     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.13012     Document Type: Article

References (35)

1. Liu D, Shriver Z, Qi Y, Venkataraman G & Sasisekharan R (2002) Dynamic regulation of tumor growth and metastasis by heparan sulfate glycosaminoglycans. Semin Thromb Hemost 28, 67-78.
2. Blackhall FH, Merry CL, Davies EJ & Jayson GC (2001) Heparan sulfate proteoglycans and cancer. Br J Cancer 85, 1094-1098.
3. Gotte M & Yip GW (2006) Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res 66, 10233-10237.
4. Presto J, Thuveson M, Carlsson P, Busse M, Wilen M, Eriksson I, Kusche-Gullberg M & Kjellen L (2008) Heparan sulfate biosynthesis enzymes EXT1 and EXT2 affect NDST1 expression and heparan sulfate sulfation. Proc Natl Acad Sci USA 105, 4751-4756.
5. Fan G, Xiao L, Cheng L, Wang X, Sun B & Hu G (2000) Targeted disruption of NDST-1 gene leads to pulmonary hypoplasia and neonatal respiratory distress in mice. FEBS Lett 467, 7-11.
6. Ringvall M, Ledin J, Holmborn K, Van KT, Ellin F, Eriksson I, Olofsson AM, Kjellen L & Forsberg E (2000) Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deacetylase/N-sulfotransferase-1. J Biol Chem 275, 25926-25930.
7. Grobe K, Inatani M, Pallerla SR, Castagnola J, Yamaguchi Y & Esko JD (2005) Cerebral hypoplasia and craniofacial defects in mice lacking heparan sulfate Ndst1 gene function. Development 132, 3777-3786.
8. Fuster MM, Wang L, Castagnola J, Sikora L, Reddi K, Lee PH, Radek KA, Schuksz M, Bishop JR, Gallo RL et al. (2007) Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis. J Cell Biol 177, 539-549.
9. Crawford BE, Garner OB, Bishop JR, Zhang DY, Bush KT, Nigam SK & Esko JD (2010) Loss of the heparan sulfate sulfotransferase, Ndst1, in mammary epithelial cells selectively blocks lobuloalveolar development in mice. PLoS One 5, e10691.
10. Liu Y, Peng H & Zhang JT (2005) Expression profiling of ABC transporters in a drug-resistant breast cancer cell line using AmpArray. Mol Pharmacol 68, 430-438.
11. Grammatikakis I, Gorospe M & Abdelmohsen K (2013) Modulation of cancer traits by tumor suppressor microRNAs. Int J Mol Sci 14, 1822-1842.
12. Wang Z, Li Y, Ahmad A, Azmi AS, Kong D, Banerjee S & Sarkar FH (2010) Targeting miRNAs involved in cancer stem cell and EMT regulation: an emerging concept in overcoming drug resistance. Drug Resist Updat 13, 109-118.
13. Bandres E, Agirre X, Bitarte N, Ramirez N, Zarate R, Roman-Gomez J, Prosper F & Garcia-Foncillas J (2009) Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer 125, 2737-2743.
14. Rodriguez A, Griffiths-Jones S, Ashurst JL & Bradley A (2004) Identification of mammalian microRNA host genes and transcription units. Genome Res 14, 1902-1910.
15. Rainer J, Ploner C, Jesacher S, Ploner A, Eduardoff M, Mansha M, Wasim M, Panzer-Grumayer R, Trajanoski Z, Niederegger H et al. (2009) Glucocorticoid-regulated microRNAs and mirtrons in acute lymphoblastic leukemia. Leukemia 23, 746-752.
16. Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y & Tokino T (2008) Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 68, 4123-4132.
17. Ozsolak F, Poling LL, Wang Z, Liu H, Liu XS, Roeder RG, Zhang X, Song JS & Fisher DE (2008) Chromatin structure analyses identify miRNA promoters. Genes Dev 22, 3172-3183.
18. Pikas DS, Eriksson I & Kjellen L (2000) Overexpression of different isoforms of glucosaminyl N-deacetylase/N-sulfotransferase results in distinct heparan sulfate N-sulfation patterns. Biochemistry 39, 4552-4558.
19. Hatzis C, Pusztai L, Valero V, Booser DJ, Esserman L, Lluch A, Vidaurre T, Holmes F, Souchon E & Wang H et al. (2011) A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA 305, 1873-1881.
20. Sarkar FH, Li Y, Wang Z, Kong D & Ali S (2010) Implication of microRNAs in drug resistance for designing novel cancer therapy. Drug Resist Updat 13, 57-66.
21. Chan SH, Huang WC, Chang JW, Chang KJ, Kuo WH, Wang MY, Lin KY, Uen YH, Hou MF & Lin CM et al. (2014) MicroRNA-149 targets GIT1 to suppress integrin signaling and breast cancer metastasis. Oncogene 33, 4496-4507.
22. Ke Y, Zhao W, Xiong J & Cao R (2013) miR-149 inhibits non-small-cell lung cancer cells EMT by targeting FOXM1. Biochem Res Int 2013, 506731.
23. Ke Y, Zhao W, Xiong J & Cao R (2013) SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer. J Pathol 229, 12-24.
24. Kulis M & Esteller M (2010) DNA methylation and cancer. Adv Genet 70, 27-56.
25. Weber M, Hellmann I, Stadler MB, Ramos L, Paabo S, Rebhan M & Schubeler D (2007) Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 39, 457-466.
26. Li SC, Tang P & Lin WC (2007) Intronic microRNA: discovery and biological implications. DNA Cell Biol 26, 195-207.
27. Chamorro-Jorganes A, Araldi E, Rotllan N, Cirera-Salinas D & Suarez Y (2014) Autoregulation of glypican-1 by intronic microRNA-149 fine-tunes the angiogenic response to fibroblast growth factor in human endothelial cells. J Cell Sci 127, 1169-1178.
28. Brenet F, Moh M, Funk P, Feierstein E, Viale AJ, Socci ND & Scandura JM (2011) DNA methylation of the first exon is tightly linked to transcriptional silencing. PLoS One 6, e14524.
29. Jones PA (2012) Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 13, 484-492.
30. Lin RJ, Lin YC & Yu AL (2010) miR-149∗induces apoptosis by inhibiting Akt1 and E2F1 in human cancer cells. Mol Carcinog 49, 719-727.
31. Shi X, Su S, Long J, Mei B & Chen Y (2011) MicroRNA-191 targets N-deacetylase/Nsulfotransferase 1 and promotes cell growth in human gastric carcinoma cell line MGC803. Acta Biochim Biophys Sin (Shanghai) 43, 849-856.
32. Bingley JA, Hayward IP, Girjes AA, Campbell GR, Humphries DE, Stow JL & Campbell JH (2002) Expression of heparan sulphate N-deacetylase/Nsulphotransferase by vascular smooth muscle cells. Histochem J 34, 131-137.
33. McKenzie EA (2007) Heparanase: a target for drug discovery in cancer and inflammation. Br J Pharmacol 151, 1-14.
34. Ma X, Cai Y, He D, Zou C, Zhang P, Lo CY, Xu Z, Chan FL, Yu S, Chen Y et al. (2012) Transient receptor potential channel TRPC5 is essential for P-glycoprotein induction in drug-resistant cancer cells. Proc Natl Acad Sci USA 109, 16282-16287.
35. Livak KJ & Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408.